优化手术患者阿片类药物处方和疼痛治疗:综述和概念框架。
Optimizing opioid prescribing and pain treatment for surgery: Review and conceptual framework.
机构信息
Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, and Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Harvard Medical School, Boston, MA, and Division of Acute Care Surgery, Beth Israel Deaconess Medical Center, Boston, MA.
出版信息
Am J Health Syst Pharm. 2019 Sep 3;76(18):1403-1412. doi: 10.1093/ajhp/zxz146.
PURPOSE
Millions of Americans who undergo surgical procedures receive opioid prescriptions as they return home. While some derive great benefit from these medicines, others experience adverse events, convert to chronic opioid use, or have unused medicines that serve as a reservoir for potential nonmedical use. Our aim was to investigate concepts and methods relevant to optimal opioid prescribing and pain treatment in the perioperative period.
METHODS
We reviewed existing literature for trials on factors that influence opioid prescribing and optimization of pain treatment for surgical procedures and generated a conceptual framework to guide future quality, safety, and research efforts.
RESULTS
Opioid prescribing and pain treatment after discharge from surgery broadly consist of 3 key interacting perspectives, including those of the patient, the perioperative team, and, serving in an essential role for all patients, the pharmacist. Systems-based factors, ranging from the organizational environment's ability to provide multimodal analgesia and participation in enhanced recovery after surgery programs to other healthcare system and macro-level trends, shape these interactions and influence opioid-related safety outcomes.
CONCLUSIONS
The severity and persistence of the opioid crisis underscore the urgent need for interventions to improve postoperative prescription opioid use in the United States. Such interventions are likely to be most effective, with the fewest unintended consequences, if based on sound evidence and built on multidisciplinary efforts that include pharmacists, nurses, surgeons, anesthesiologists, and the patient. Future studies have the potential to identify the optimal amount to prescribe, improve patient-focused safety and quality outcomes, and help curb the oversupply of opioids that contributes to the most pressing public health crisis of our time.
目的
在美国,数以百万计的接受手术的患者在出院时会收到阿片类药物处方。虽然有些人从中受益良多,但也有些人出现不良反应,转为慢性阿片类药物使用,或者有未使用的药物,成为潜在非医疗用途的储备。我们的目的是研究与围手术期阿片类药物处方和疼痛治疗优化相关的概念和方法。
方法
我们回顾了有关影响手术期间阿片类药物处方和疼痛治疗优化的因素的现有文献,并生成了一个概念框架,以指导未来的质量、安全和研究工作。
结果
手术后出院时的阿片类药物处方和疼痛治疗大致包括 3 个关键的相互作用视角,包括患者、围手术期团队,以及药剂师,他们在所有患者中发挥着至关重要的作用。系统因素,从组织环境提供多模式镇痛和参与手术后加速康复计划的能力,到其他医疗保健系统和宏观层面的趋势,都影响了这些相互作用,并影响了与阿片类药物相关的安全结果。
结论
阿片类药物危机的严重性和持续存在突显了迫切需要采取干预措施来改善美国术后处方阿片类药物的使用。如果这些干预措施基于可靠的证据,并建立在包括药剂师、护士、外科医生、麻醉师和患者在内的多学科努力基础上,那么这些干预措施最有可能取得最佳效果,同时减少意外后果。未来的研究有可能确定最佳的处方量,改善以患者为中心的安全和质量结果,并有助于遏制导致我们这个时代最紧迫公共卫生危机的阿片类药物供应过剩。